{"id":1038988,"date":"2012-02-29T18:40:11","date_gmt":"2012-02-29T18:40:11","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/uncategorized\/acm-global-central-lab-launches-workshop-series-to-share-expert-insights-on-navigating-global-clinical-trials-with-a.php"},"modified":"2024-08-17T16:23:04","modified_gmt":"2024-08-17T20:23:04","slug":"acm-global-central-lab-launches-workshop-series-to-share-expert-insights-on-navigating-global-clinical-trials-with-a","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pharmacogenomics\/acm-global-central-lab-launches-workshop-series-to-share-expert-insights-on-navigating-global-clinical-trials-with-a.php","title":{"rendered":"ACM Global Central Lab Launches Workshop Series to Share Expert Insights on Navigating Global Clinical Trials with a &#8230;"},"content":{"rendered":"<p><p>    ROCHESTER, N.Y.--(BUSINESS WIRE)--  <\/p>\n<p>    ACM Global Central Lab, the central laboratory that continually    defines the customer-service standard with its flexible    approach, today announced the launch of its complimentary    workshop series,     Navigating Global Clinical Trials with Your Central Lab,    designed for global pharmaceutical and biotechnology companies    and contract research organizations (CROs) interested in    managing global clinical trials testing. The first    workshop,    Ensuring Patient Safety through Efficient Specimen Lifecycle    Management, will take place Thursday, March 15, 2012, from    2:00  5:00 p.m. PST at Hotel Vitale in San Francisco.  <\/p>\n<p>    In many clinical trial scenarios, there may only be one chance    to collect, ship, test and analyze a patients specimen. These    often time-sensitive snapshots into a patients progression in    a study are critical not only to the overall study results, but    ultimately the safety of patients undergoing treatment. The    lifecycle of a specimen, which starts at collection and ends at    database lock, can be prone to human error along each step of    the testing process, particularly when conducting global    clinical trials in more remote ends of the world. Sponsors need    to ensure the integrity of the specimen throughout this    process, while balancing the relative cost of logistics.  <\/p>\n<p>    There are many considerations when it comes to conducting    global studies, said Tracy Hendershott, vice president of    clinical trials at ACM Global Central Lab. As a central lab    devoted to clinical trials testing, we wanted to develop a    workshop series to support the clinical trials community by    helping them navigate the many hurdles and offer some new    approaches that can improve efficiencies along the way.  <\/p>\n<p>    Executives from ACM Global Central Lab,     Cryoport and     Dorevitch Pathology will be discussing the scientific,    financial and logistical factors that should be considered to    ensure patient safety and will offer innovative, yet    cost-effective methodologies and solutions for maintaining    specimen integrity. During interactive presentations and a    networking reception, attendees will have the opportunity to    hear from ACM Global Lab and its partners on their insights on    monitoring and oversight on patient safety, safeguarding sample    integrity, and good business sense, based on lessons learned    from managing global clinical trials testing.  <\/p>\n<p>    To register for ACM Global Central Labs complimentary    workshop, please     click here. Registrants will automatically qualify to be    entered into a drawing for a Sunset    Sailing Experience for Two around the San Francisco Bay.  <\/p>\n<p>    About ACM Global Central Lab    ACM Global Central Lab offers a flexible approach and a focus    on precision to keep clinical research studies on schedule.    ACMs services extend to more than 60 countries with all tests    conducted and managed from central lab facilities with seamless    data management providing a single database. The organization    performs 13 million tests each year, featuring more than 1,500    individual tests spanning all medical disciplines, including    pathology, microbiology, flow cytometry and pharmacogenomics.    Combining comprehensive safety, efficacy and pathology testing    from a single lab ensures clients receive consistent,    analyzable test results with faster and cleaner reporting.  <\/p>\n<p>    For more information, visit     <a href=\"http:\/\/www.acmgloballab.com\" rel=\"nofollow\">http:\/\/www.acmgloballab.com<\/a> and our Central Labs in Focus blog    atwww.acmgloballab.com\/blog.  <\/p>\n<\/p>\n<p>Continue reading here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/acm-global-central-lab-launches-140000903.html\" title=\"ACM Global Central Lab Launches Workshop Series to Share Expert Insights on Navigating Global Clinical Trials with a ...\" rel=\"noopener\">ACM Global Central Lab Launches Workshop Series to Share Expert Insights on Navigating Global Clinical Trials with a ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> ROCHESTER, N.Y.--(BUSINESS WIRE)-- ACM Global Central Lab, the central laboratory that continually defines the customer-service standard with its flexible approach, today announced the launch of its complimentary workshop series, Navigating Global Clinical Trials with Your Central Lab, designed for global pharmaceutical and biotechnology companies and contract research organizations (CROs) interested in managing global clinical trials testing. The first workshop, Ensuring Patient Safety through Efficient Specimen Lifecycle Management, will take place Thursday, March 15, 2012, from 2:00 5:00 p.m. PST at Hotel Vitale in San Francisco <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pharmacogenomics\/acm-global-central-lab-launches-workshop-series-to-share-expert-insights-on-navigating-global-clinical-trials-with-a.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246862],"tags":[],"class_list":["post-1038988","post","type-post","status-publish","format-standard","hentry","category-pharmacogenomics"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1038988"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1038988"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1038988\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1038988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1038988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1038988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}